Measurement of the Structural Efficacy in Active RA Patients Treated With Sarilumab in Combination With MTX and Naive to Biologics

NCT03535402 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

20

Enrollment

INDIV

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: Sarilumab

Sponsor

Gaylis, Norman B., M.D.